IGF2 and metabolic disease: However, overexpression of IGF-II in the LDLR–/–ApoB100/100 background results in impaired glucose tolerance, insulin resistance, and moderately increased blood glucose levels [16], which together simulate more of a metabolic disorder or a prediabetic state rather than full-blown diabetes.